ScholarIQanswers from OpenAlex

Rituximab Therapy in Idiopathic Membranous Nephropathy

PaperCitations, authors & open-access status

Rituximab Therapy in Idiopathic Membranous Nephropathy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Rituximab Therapy in Idiopathic Membranous Nephropathy have?

ScholarIQcitation count

Rituximab Therapy in Idiopathic Membranous Nephropathy has 300 citations in the OpenAlex counts ScholarIQ stores.

When was Rituximab Therapy in Idiopathic Membranous Nephropathy published?

ScholarIQyear

Rituximab Therapy in Idiopathic Membranous Nephropathy has 2010 year in the ScholarIQ index.

What is the open-access status of Rituximab Therapy in Idiopathic Membranous Nephropathy?

ScholarIQoa status

Rituximab Therapy in Idiopathic Membranous Nephropathy has green oa status in the ScholarIQ index.

What is the DOI of Rituximab Therapy in Idiopathic Membranous Nephropathy?

ScholarIQdoi

The DOI for Rituximab Therapy in Idiopathic Membranous Nephropathy is on the source record.

What is the PMID of Rituximab Therapy in Idiopathic Membranous Nephropathy?

ScholarIQpmid

The PMID for Rituximab Therapy in Idiopathic Membranous Nephropathy is on the source record.

What is the OpenAlex record for Rituximab Therapy in Idiopathic Membranous Nephropathy?

ScholarIQopenalex

The OpenAlex for Rituximab Therapy in Idiopathic Membranous Nephropathy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial